|
ERF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51871999999331E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33569999996686E-06 |
| Normal-vs-Stage2 |
8.17999999958019E-08 |
| Normal-vs-Stage3 |
2.156100E-03 |
| Normal-vs-Stage4 |
3.196900E-03 |
| Stage1-vs-Stage2 |
2.740200E-02 |
| Stage1-vs-Stage3 |
4.847800E-02 |
| Stage1-vs-Stage4 |
9.763400E-01 |
| Stage2-vs-Stage3 |
2.820900E-03 |
| Stage2-vs-Stage4 |
2.096400E-01 |
| Stage3-vs-Stage4 |
2.767000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83923999999003E-05 |
| Normal-vs-AfricanAmerican |
1.29159999995299E-06 |
| Normal-vs-Asian |
1.713700E-02 |
| Caucasian-vs-AfricanAmerican |
1.627380E-01 |
| Caucasian-vs-Asian |
6.369000E-01 |
| AfricanAmerican-vs-Asian |
9.431000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67721999999593E-05 |
| Normal-vs-Female |
4.72039999999119E-06 |
| Male-vs-Female |
6.102400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.5305000000152E-06 |
| Normal-vs-Extreme_Weight |
5.8310000050632E-08 |
| Normal-vs-Obese |
8.08740000000086E-05 |
| Normal-vs-Extreme_Obese |
4.003300E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.792000E-01 |
| Normal_Weight-vs-Obese |
7.622400E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.027000E-01 |
| Extreme_Weight-vs-Obese |
9.055700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.683400E-01 |
| Obese-vs-Extreme_Obese |
3.726600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.535600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.9941999999924E-05 |
| Normal-vs-Age(61-80Yrs) |
8.73449999994058E-07 |
| Normal-vs-Age(81-100Yrs) |
3.578400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.621000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.162000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.838600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.856380E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.501200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.055200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.57099999999311E-05 |
| Normal-VS-Type2 PRCC |
8.2365999998224E-07 |
| Normal-VS-KIRP CIMP |
8.099300E-03 |
| Normal-VS-Unclassified PRCC |
1.63349999999785E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.927500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.477000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.265600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.160200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.681800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.134800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89289999996678E-06 |
| Normal-vs-N1 |
1.120150E-03 |
| Normal-vs-N2 |
7.370300E-02 |
| N0-vs-N1 |
2.460000E-01 |
| N0-vs-N2 |
9.529200E-01 |
| N1-vs-N2 |
5.884600E-01 |
|
|
